Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-018090
Filing Date
2017-07-07
Accepted
2017-07-07 19:13:33
Documents
1
Period of Report
2017-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12125
  Complete submission text file 0000899243-17-018090.txt   13762
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTON STREET SUITE 3310 BOSTON MA 02199
Business Address 800 BOYLSTON STREET SUITE 3310 BOSTON MA 02199 617-391-0403
AJU IB Investment Co., Ltd. (Reporting) CIK: 0001710065 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 17956077